-
Symbol
-
TLSI on Nasdaq
-
Investment type
-
Equity / Common stock, $0.0001 par value
-
Latest Disclosed Ownership
-
6.99M shares
-
Security Ownership
-
14%
Frankenius Equity AB ownership in TriSalus Life Sciences, Inc. Common stock, $0.0001 par value (TLSI)
2025-08-04 - Frankenius Equity AB has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.99M shares of TriSalus Life Sciences, Inc. Common stock, $0.0001 par value (TLSI).
This represents 14% percent ownership of the company.
In their previous filing dated 2025-05-02, Frankenius Equity AB had reported owning 6.73M shares, indicating an increase of 3.82% percent.